Diane-35® (2mg cyproterone acetate and 0.035mg ethinyl estradiol) - A - Detailing from Skin Therapy Letter

 

Diane-35® (2mg cyproterone acetate and 0.035mg ethinyl estradiol)

 

 

  Content:

CLINICAL EXPERIENCE

 

 

  • Diane-35® (2mg cyproterone acetate and 0.035mg ethinyl estradiol) is approved for use in Canada to treat women with severe acne who are unresponsive to other available treatments and who have associated symptoms of androgenization, such as seborrhea and mild hirsutism. In addition to treating acne, Diane-35® also provides reliable contraception.
  • The drug is well tolerated. Any adverse effects are mild to moderate in intensity and are typical of those associated with oral contraceptives.
  • Diane-35 is the only estrogen/progestogen combination in which the progestin component is an antiandrogen and a derivative from 17-hydroxyprogesterone while others derive from 19-nortestosterone.
  • Diane-35® is considered the treatment of choice for women with acne (that appears after adolescence). It is currently used by more than 3 million women in more than 100 countries.

Next:   Indications

 

 

    More Presentations: